Ligand validation:3S2G

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3S2G designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3S2G_NAD_H_1250	59%	4%	0.142	0.923	2.92	2.73	19	14	4	0	100%	1
3S2G_NAD_G_1250	54%	4%	0.152	0.915	2.93	2.82	19	14	5	0	100%	1
3S2G_NAD_F_1250	34%	4%	0.194	0.877	2.94	2.67	19	12	6	0	100%	1
3S2G_NAD_E_1250	21%	4%	0.215	0.827	2.93	2.69	19	13	3	0	100%	1
3S2E_NAD_G_1250	95%	5%	0.066	0.968	2.75	2.66	15	12	1	0	100%	1
3S2F_NAD_F_1250	75%	18%	0.11	0.943	1.78	1.78	10	5	7	5	100%	1
3S2I_NAD_G_1250	58%	2%	0.142	0.922	3.09	3.84	18	15	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.